Aro Biotherapeutics

Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines using their proprietary protein technology called Centyrins. The company focuses on creating receptor-targeted genetic medicines by selectively modulating gene targets in disease tissues to achieve superior efficacy and safety. Based in Philadelphia, Aro develops a wholly-owned pipeline of Centyrin-based therapeutic candidates and collaborates with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics across diverse diseases.

Company Facts

• Headquarters: Philadelphia, United States
• Type: Private Company
• Website: https://www.arobiotx.com
• Industries: Biotechnology, Genetic Medicine, Pharmaceutical Development, Therapeutic Development